Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Medicinova Inc (MNOV)  
$1.33 0.02 (1.48%) as of 4:30 Thu 5/30


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 44,930,000
Market Cap: 59.76(M)
Last Volume: 13,996 Avg Vol: 310,930
52 Week Range: $1.28 - $2.6
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   MediciNova is a biopharmaceutical company. Co. is focusing its development activities on MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, substance dependence and addiction and prevention of acute respiratory distress syndrome, and MN-001 (tipelukast) for fibrotic diseases such as nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis. Co.'s pipeline also includes MN-221 (bedoradrine) for the treatment of acute exacerbation of asthma and MN-029 (denibulin) for solid tumor cancers.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 12,646
Total Sell Value $0 $0 $0 $28,031
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 4
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 89
  Page 4 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Iwaki Yuichi Chief Executive Officer   •       •      –    2007-10-04 4 AB $8.21 $10,673 I/I 1,300 627,851     -
   Iwaki Yuichi Chief Executive Officer   •       •      –    2007-10-03 4 AB $8.10 $23,490 I/I 2,900 626,551     -
   Iwaki Yuichi Chief Executive Officer   •       •      –    2007-10-02 4 AB $8.11 $23,519 I/I 2,900 623,651     -
   Iwaki Yuichi Chief Executive Officer   •       •      –    2007-10-01 4 AB $7.90 $23,322 I/I 2,900 620,751     -
   Iwaki Yuichi Chief Executive Officer   •       •      –    2007-09-21 4 D $7.36 $367,831 I/I (49,977) 617,851     -
   Iwaki Yuichi Chief Executive Officer   •       •      –    2007-09-21 4 OE $1.00 $367,828 I/I 367,828 667,828     -
   Tanabe Holding America Inc. 9.9% owner   –       –      –    2006-10-13 4 D $1.00 $5,000,000 D/D (5,000,000) 5,000,000     -
   Iwaki Yuichi Chief Executive Officer   •       •      –    2006-08-07 4 OE $0.10 $150,000 I/I 1,500,000 3,000,000     -
   Iwaki Yuichi Acting CEO   •       •      –    2006-03-02 4 OE $0.10 $125,000 I/I 1,250,000 1,500,000     -
   Himawan Jeff officerTitle   –       •      –    2006-01-09 3 IO $0.00 $0 I/I 0 11,703,704     -
   Tanabe Holding America Inc. 10% Owner   –       –       •   2005-01-28 3 IO $0.00 $0 D/D 0 10,000,000     -
   Kiyoizumi Takashi President and CEOOfficer   •       •      –    2005-01-28 3 IO $0.00 $0 D/D 0 250,000     -
   Essex Woodlands Health Ventures Fund Vi L P 10% Owner   –       –       •   2005-01-28 3 IO $0.00 $0 D/D 0 11,703,704     -
   Iwaki Yuichi Director   –       •      –    2005-01-28 3 IO $0.00 $0 D/D 0 250,000     -
  89 Records found
  1  2  3  4    
  Page 4 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us